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Introduction
Decision models are commonly used to evaluate the cost-effectiveness of health interventions. They are populated with input parameters estimated from various sources; however, the true values of these parameters are not known with certainty, which may result in suboptimal decisions. (1) The preferred approach to characterise decision uncertainty is to conduct probabilistic sensitivity analysis (PSA) whereby uncertainty is propagated in the model using Monte Carlo simulation.(2) Decision uncertainty is then presented as the probability that each intervention has the highest expected net benefit (i.e., benefits minus costs). Nevertheless, an important additional step is to know whether a decision can be made based on current evidence or if additional research is required. This can be informed using value of information (VOI) analysis.(3) Measures of VOI include (1) the expected value of perfect information (EVPI), which is the maximum value of additional information to resolve all uncertainty in the parameters; (2) the expected value of perfect parameter information (EVPPI), which is the value of resolving uncertainty in a given parameter or set of parameters; and (3) the expected value of sample information (EVSI), which estimates the value of a particular data collection exercise (e.g. a randomised controlled trial with some chosen sample size) in reducing decision uncertainty. (4) EVPI calculation is straightforward given the PSA; however, although this measure is necessary, it is not sufficient to inform decisions because it represents only an upper-bound of the value of additional research to resolve uncertainty.(3) Rather, it is important to know which parameters are contributing most to decision uncertainty, such that further research should focus on these. Here, the EVPPI for some parameter represents the value of eliminating uncertainty about that parameter, and therefore gives an upper-bound on the value of a study to inform that parameter. The EVSI meanwhile represents the value of a given study design in reducing parameter uncertainty. (5) Comparing the EVSI with the expected cost of a research study establishes a sufficient condition to inform whether additional research is worthwhile. Unfortunately, the reporting of EVSI and EVPPI estimates in economic evaluations remains limited because of the perceived computational burden associated with these two measures. (6) (7) (8) The EVPPI for a single parameter or a group of parameters is typically calculated Carlo simulation (or some similar approach) will be necessary. (6, 7) In some situations, most notably in multi-linear (i.e. sum-product type) models (e.g., decision tree) where the net benefit is a linear function of the cost and effect parameters, or when the incremental net benefit is approximately normally distributed, one-level Monte Carlo simulation or analytical equations can be used. (11, 16, 17) However, there is a wide class of models for which these constraints do not apply.
Methods for efficient EVPPI calculation of single parameters have been developed. These show promise, but do not extend to groups of parameters simultaneously. (18, 19) A method based on the numerical approximation of the posterior expected net benefit, conditional on sampled data, has been proposed as an efficient approach for EVSI calculation; however, it requires significant skills and effort to write the necessary computer In this paper we apply the non-parametric regression method to calculate the EVPPI and the EVSI in two decision models for two healthcare interventions. In addition, we compare the results and computation time with the estimates obtained using Monte Carlo simulation.
Methods

The two economic models
We conducted two cost-effectiveness analyses using two decision models constructed The two models were probabilistic; input parameters were assigned probability distributions. In general, beta distributions for probabilities and utilities, gamma distributions for costs and disutilities, and lognormal distributions for relative risks.(22, 23) For the set of unknown input parameters ( ), each model predicted the net benefit (NB) for each intervention (i), thus NB (i, ) = willingness-to-pay* Effect (i, ) -Cost (i, ). The efficacy outcome in the two models was quality-adjusted life-years (QALYs) gained, and we set the willingness-to-pay threshold at $50,000/QALY. The preferred intervention would be the one with the maximum expected NB (max i E NB (i, )). In each case, a PSA was performed using Monte Carlo simulation (10,000 iterations) to characterise decision uncertainty.
Value of information calculation
We calculated VOI measures using the standard Monte Carlo and the Strong et al.
non-parametric regression approach for each of the two decision models. We also recorded, for each decision problem, the computation time for each VOI approach.
Methods to calculate value of information measures using Monte Carlo simulations are described in detail elsewhere. (11, 24, 25) In summary, we started our analysis by calculating the EVPI, which is the difference between the expected NB of a decision with perfect information and the decision based on current information:(3)
EVPI = E max i NB (i, ) -max i E NB (i, )
Equation 1 The EVPPI for the parameter(s) of interest I is the difference between the expected NB with perfect information on these parameters, conditional on the complementary set of other parameters C , and the expected NB with current information: (5, 25)
Equation 2
For the pressure ulcer Markov model, we performed two nested Monte Carlo simulation procedures with 1,000 simulations in each loop. We found this number of simulations sufficient for the estimates to converge. (25) We assumed the NPWT model is linear with no correlation between input parameters, and therefore, a one-level simulation scheme was used in which we sampled from I , but kept C fixed at their prior mean. (25) The EVSI is the difference between the expected value of a decision made after collecting data (D) on the parameter(s) of interest and the expected NB with current information: (11) Equation 3 We assumed the prior distribution and data were conjugate distributions, and thus, the posterior distribution was known in closed form. (11, 14) We conducted a two-level Monte
Carlo simulation with 1,000 iterations in each of the inner and outer loops for the Markov pressure ulcer model. (11) For the NPWT decision tree, we avoided nested simulation in estimating the NBs by "plugging in" the prior means of C and the posterior means of I . (11) We repeated EVPPI and EVSI calculations for the two models using regression methods in R software as described by Strong et al. (9, 21) Using the PSA sample of 10,000
iterations (K =10,000), we fitted a regression model for each decision option. After that we extracted the regression model fitted values denoted as and calculated EVPPI via:
Equation 4 To calculate EVSI, we generated data and calculated summary statistic D k conditional on each sample in the PSA. For the relative risk parameter for example, we calculated the summary statistics by generating a sample data of the probability of the event in the intervention group ( ) from a Binomial ( , n) and for the control group ( ) from a Binomial ( , n); thus, D k = log ( Then we fitted a regression model for each decision option and extracted the regression model fitted values denoted as . EVSI was estimated via: (21) Equation 5 
Results
The incremental NB of NPWT was $70 with 65% probability being cost-effective.
The per-person EVPI was $76. The parameter with the highest EVPPI was the relative risk of surgical site infection. The per-person EVPPI was estimated at $75 using Monte Carlo simulation, and $74 using non-parametric regression. The per-person EVSI for a future study to inform this parameter was $63 when calculated with Monte Carlo simulation compared with $61 using regression. The calculation time for the EVPPI and EVSI measure was short (around one minute) in both Monte Carlo simulation and non-parametric regression.
For nutritional support intervention, the incremental NB was $675 indicating it is cost-effective. The probability this intervention is cost-effective was 85%, and the per-person EVPI was $33. The parameter with the highest per-person EVPPI value was the relative risk of pressure ulcer which had a value of $17 under both methods of computation. The perperson EVSI of a study to inform this parameter was approximately $6 under both approaches. In terms of the computation time, non-parametric regression estimated EVPPI
and EVSI values in less than one minute and in one step. For the Monte Carlo simulation, every EVPPI estimate took around four hours, and every EVSI value for a given sample size took around eight hours. Table 1 summarises the results and Figure 1 illustrates the EVSI curves from the two models.
Discussion
This study reports the first comparison of the non-parametric regression and Monte can be calculated and presented. We anticipate that the uptake of this efficient approach will increase as time passes. This will hopefully encourage more reporting of VOI estimates in economic evaluations and encourage a wider adoption of VOI analysis as a useful tool to inform funding decisions and to optimise research design and prioritisation.
It is worth mentioning that another efficient approach has been recently proposed by Jalal and Kuntz for EVSI calculation from a PSA sample. (27) In their method, they use linear regression metamodeling with the assumption that the incremental NB is normally distributed. (27) Unfortunately, the normality assumption, and the assumption of linearity of the model could make it difficult to generalise this approach.(28) However, it would be interesting to see how the two regression approaches, and other efficient methods, compare using models of various types. It would be useful also to compare the performance of these efficient methods with Monte Carlo simulation using more complex models such as those using microsimulation, or models with non-conjugate priors (e.g., Weibull distribution), or with correlated parameters.
In conclusion, the non-parametric regression-based approach provides an efficient, flexible and easy-to-implement alternative for EVPPI and EVSI calculation in economic models. The approach should facilitate the wider incorporation of VOI analysis in decision frameworks. 
